Table 3.

Results (median and range) of comparisons between the factors and various clinical/laboratory parameters.

Variables	MUC2 (ng/mL)	p
Age, years
Younger (<50 years)	185.5 (8–640)	0.90
Older (≥50 years)	200.0 (4-668)
Grade
I–II (Good–medium)	215 (10–668)	0.42
III (Poor)	183.5 (4–560)
Estrogen Receptor
Negative	135 (4–560)	0.21
Positive	202.5 (8–668)
Progesteron Receptor
Negative	184 (4–668)	0.43
Positive	205 (10–560)
HER-2
Negative	205 (8–668)	0.51
Positive	160 (4–560)
Classification HER-2 -negative luminal Others	205 (8–668) 160 (4–560)	0.46
Classification Triple-positive Others	183 (50–560) 201.5 (4–668)	0.73
Classification
HER-2 disease Others	96 (4–475) 202.5 (8–668)	0.13
Classification Triple-negative Others	196 (38–560) 198 (4–668)	0.77
T stage
1 (small)	234 (10–496)	0.41
2-4 (large)	185 (4–668)
N status
Negative	234 (10–490)	0.66
Positive	190.5 (4–668)
M stage
M0	198 (4–668)	0.65
M1	195 (20–640)
Serum LDH level (ULN: 450 U/L)
Normal	200 (10–668)	0.47
Elevated	175 (4–640)
Serum CA15-3 level (ULN: 35 U/mL)
Normal	198 (4–668)	0.84
Elevated	200.5 (14–560)
Response to CT
Yes No	184.5 (8–668) 270 (50–400)	0.53

LDH: lactate dehydrogenase, ULN: upper limit of normal; CT: chemotherapy.